Asia Pacific Opioids Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Asia Pacific Opioids Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Asia Pacific Opioids Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Geriatric population

5.2 Market Opportunities

5.2.1 Strategic Initiatives by Market Players

5.3 Future Trends

5.3.1 Increasing Government Initiatives Focusing on the Development of Medication to Prevent and Treat Opioid Use Overdose and Disorder

5.4 Impact of Drivers and Restraints

6. Asia Pacific Opioids Market Regional Analysis

6.1 Asia Pacific Opioids Market Overview

6.2 Asia Pacific Opioids Market Revenue 2020-2030 (US$ Million)

6.3 Asia Pacific Opioids Market Forecast Analysis

7. Asia Pacific Opioids Market Analysis – by Product

7.1 Immediate Release Short Acting Opioid

7.1.1 Overview
7.1.2 Immediate Release Short Acting Opioid: Asia Pacific Opioids Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Extended Release Long Acting Opioid

7.2.1 Overview
7.2.2 Extended Release Long Acting Opioid: Asia Pacific Opioids Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Opioids Market Analysis – by Application

8.1 Pain Management

8.1.1 Overview
8.1.2 Pain Management: Asia Pacific Opioids Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Anesthesia

8.2.1 Overview
8.2.2 Anesthesia: Asia Pacific Opioids Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Diarrhea Suppression

8.3.1 Overview
8.3.2 Diarrhea Suppression: Asia Pacific Opioids Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Cough Suppression

8.4.1 Overview
8.4.2 Cough Suppression: Asia Pacific Opioids Market – Revenue and Forecast to 2030 (US$ Million)

8.5 De-Addiction

8.5.1 Overview
8.5.2 De-Addiction: Asia Pacific Opioids Market – Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Opioids Market Analysis – by Route of Administration

9.1 Oral

9.1.1 Overview
9.1.2 De-Addiction: Asia Pacific Opioids Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Injectable

9.2.1 Overview
9.2.2 De-Addiction: Asia Pacific Opioids Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Transdermal Patch

9.3.1 Overview
9.3.2 De-Addiction: Asia Pacific Opioids Market – Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Opioids Market – Asia-Pacific Analysis

10.1 Asia-Pacific

10.1.1 Asia Pacific Opioids Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 Asia Pacific Opioids Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China: Asia Pacific Opioids Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 China: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.1.2 China: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.1.3 China: Asia Pacific Opioids Market Breakdown, by Route of Administration

10.1.1.2 India: Asia Pacific Opioids Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 India: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.2.2 India: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.2.3 India: Asia Pacific Opioids Market Breakdown, by Route of Administration

10.1.1.3 Japan: Asia Pacific Opioids Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Japan: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.3.2 Japan: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.3.3 Japan: Asia Pacific Opioids Market Breakdown, by Route of Administration

10.1.1.4 Australia: Asia Pacific Opioids Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Australia: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.4.2 Australia: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.4.3 Australia: Asia Pacific Opioids Market Breakdown, by Route of Administration

10.1.1.5 Rest of Asia-Pacific : Asia Pacific Opioids Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Opioids Market Breakdown, by Product
10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Opioids Market Breakdown, by Application
10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Opioids Market Breakdown, by Route of Administration

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Asia Pacific Opioids Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Endo International plc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Mallinckrodt Plc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Neuraxpharm Pharmaceuticals SL

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Mayne Pharma Group Ltd

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Rusan Pharma Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Teva Pharmaceutical Industries Ltd

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights